Global /India /Healthcare /Drug Manufacturers - General /AHCL

Anlon Healthcare Ltd.

AHCL

• NSE: AHCL • Delayed

13.30INR -1%

0.1409 USD

As of 24 June 2026, Anlon Healthcare Ltd. has a market cap of $75.48M USD, ranking #27548 globally and #1737 in India. It ranks #2484 in the Healthcare sector, and #893 in the Drug Manufacturers - General industry.

Global Rank

27548

Country Rank

1737

Sector Rank

2484

Industry Rank

893

Key Stats

Market Cap

$75.48MUSD

7.14B INR

Enterprise Value

$77.14MUSD

7.28B INR

Revenue (TTM)

$17.98MUSD

1.7B INR

EBITDA (TTM)

$5.26MUSD

496.89M INR

Net Income (TTM)

$3.67MUSD

346.64M INR

EBITDA Margin

29%

Profit Margin

20%

PE Ratio

17.1

PS Ratio

4.2

PB Ratio

3.3

EV/EBITDA

14.7

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Punitkumar Rasadia open_in_new

Employees

117

Founded

2013

Website

anlon.in open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1%	-7%	16%	4.6%	8.3%	-11%	75%	75%	75%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	AHCL ISIN: INE0Y8W01025 Shares Out.: Shares Outstanding: 531.515M¹ Shares Float: 125.137M² TV: TradingView: NSE: AHCL SA: Stock Analysis: NSE: AHCL YF: Yahoo Finance: AHCL.NS GF: Google Finance: NSE: AHCL BA: Barron's: AHCL MS: Morningstar: XNSE: AHCL	13.30 INR	TV: TradingView: NSE: AHCL SA: Stock Analysis: NSE: AHCL YF: Yahoo Finance: AHCL.NS GF: Google Finance: NSE: AHCL BA: Barron's: AHCL MS: Morningstar: XNSE: AHCL
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	AHCL ISIN: INE0Y8W01025 TV: TradingView: BSE: AHCL SA: Stock Analysis: BOM: AHCL YF: Yahoo Finance: AHCL.BO GF: Google Finance: BOM: AHCL BA: Barron's: AHCL MS: Morningstar: XBOM: AHCL	16.09 INR	TV: TradingView: BSE: AHCL SA: Stock Analysis: BOM: AHCL YF: Yahoo Finance: AHCL.BO GF: Google Finance: BOM: AHCL BA: Barron's: AHCL MS: Morningstar: XBOM: AHCL

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Anlon Healthcare Ltd.

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas. The company was incorporated in 2013 and is based in Rajkot, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.13B 4.27T INR 60K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.34B 1.73T INR 24K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.14B 1.43T INR 20K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.71B 1.11T INR 15K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.85B 931.67B INR 13K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.69B 916.53B INR 13K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 1M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 725K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 478K%	97.4	United States
Roche Holding AG SIX: RO	$316.71B 256.25B CHF 419K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$285.49B 215.59B GBP 378K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 363K%	15.1	United States

chevron_leftBack